Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00088803 · ClinicalTrials.gov registry record
DNA Variations in the Gene in Young Patients With Wilms' Tumor
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 471
- Enrollment target
NCT00088803 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 471 participants.
The verdict
NCT00088803 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 471 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. PURPOSE: This laboratory study is looking at DNA variations in the RASSF1A gene in young patients with Wilms' tumor.
Interventions
- GENETIC polymerase chain reaction
- GENETIC molecular genetic technique
- GENETIC polymorphism analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 471 participants |
| Start Date | 2004-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00088803
The ClinicalTrials.gov registry entry for NCT00088803 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 471 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which polymerase chain reaction is the first listed.
NCT00088803 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00088803 about?
NCT00088803 is a clinical study titled "DNA Variations in the Gene in Young Patients With Wilms' Tumor". RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. PURPOSE: This laboratory study is looking at DNA variations in the RASSF1A gene in young patients with Wilms' t...
What is the current status of trial NCT00088803?
This trial is currently completed. The enrollment target is 471 participants. The study started on 2004-08.
What interventions are being tested in trial NCT00088803?
The interventions under investigation include: polymerase chain reaction (GENETIC), molecular genetic technique (GENETIC), polymorphism analysis (GENETIC).
Who is sponsoring clinical trial NCT00088803?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.